Roche Sponsored Webinar: Small Patients, Big Risks: Neonatal and Pediatric Sepsis

Roche Sponsored Webinar: Small Patients, Big Risks: Neonatal and Pediatric Sepsis

Product not yet rated

Includes a Live Web Event on 10/22/2026 at 11:00 AM (PDT)

Webinar Description: 

Neonatal and pediatric sepsis present unique clinical challenges, ranging from non-specific symptoms to the limitations of traditional blood cultures in tiny patients. This sponsored webinar explores how diagnostic strategies and biomarkers, including Procalcitonin (PCT) and Interleukin-6 (IL-6) can help cut through the clinical noise. Join us to learn about early detection, enable targeted therapies, and safely reduce empiric antibiotic use in our most vulnerable patients.

No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

Webinar Sponsor: 

Sepsis Alliance gratefully acknowledges the support provided by Roche for this sponsored webinar.

image


Emin Maltepe, MD, PhD

Emin Maltepe, MD, PhD

Professor of Pediatrics

University of California San Francisco

Emin Maltepe, MD, PhD, is a Professor of Pediatrics at UCSF. His research laboratory studies mechanisms whereby hypoxia signaling pathways regulate normal development, contribute to the origins of pregnancy complications, and drive disease processes such as pulmonary hypertension and retinopathy of prematurity in newborn infants. Additionally, he is a co-founder of the Initiative for Pediatric Drug and Device Development (www.ipd3.org), a multi-institutional collaborative comprised of leaders in pediatrics and pharmaceutical sciences that functions as a ”one-stop-shop” to advance drug and device development for pediatric indications. In this capacity, the collaborative has been working with non-profit and industry sponsors on multiple fronts, including neurotherapeutics for birth asphyxia, novel oxygen delivery biotherapeutics for treatment of hemorrhagic shock, as well as cardioprotective agents for infants undergoing repair of congenital heart defects. He is additionally helping advise the development of novel diagnostic modalities specifically targeting sepsis as well as brain injury in newborn infants.

Components visible upon registration.